Volume 8, Issue 2 (9-2022)                   CJP 2022, 8(2): 0 | Back to browse issues page

XML Print

Pediatric Hematology and Oncology Department, Tehran University of Medical Sciences, Tehran, Iran , mkajiyazdi@sina.tums.ac.ir
Abstract:   (1226 Views)
Background and Objective: Neonatal thrombocytopenia (NTP) is one of the most common neonatal hematological disorders. The causes of NTP are very various, leading to large differences in the clinical profile of the affected neonates. Therefore, the aim of this study was to investigate the characteristics, clinical diagnoses and short-term outcomes of NTP in Bahrami Children's Hospital, Iran.
Methods: This descriptive retrospective cross-sectional study was conducted on all neonates admitted to the neonatal intensive care unit (NICU) of Bahrami Children's Hospital in 2017-2019. The infants diagnosed with NTP, defined as a platelet count of <150000 on at least 2 occasions, were retrospectively evaluated. Data on patients' NTP and short-term outcomes were reported. Incomplete medical records were excluded from the study.
Findings: Out of 2000 neonates, 210 patients were diagnosed with NTP with a prevalence of 10.5%. Totally, 60% and 71.4% of infants were premature and underweight, respectively. Moreover, 30 and 20.9% of infants had premature and severe NTP, respectively. The most common clinical diagnosis was sepsis (68.1%). The mean length of stay in NICU was 12.3±9.5 days. Additionally, 20.9% of infants had at least one episode of severe hemorrhage, received a platelet transfusion, and 10.4% of infants expired during their NICU stay.
Conclusion: The prevalence of NTP was 10.5%. Despite the relatively high prevalence of preterm birth, low-birth weight and sepsis, the majority of our neonates recovered. Prospective studies are recommended to investigate the role of each predisposing factor in the development and outcome of NTP.
Full-Text [PDF 521 kb]   (229 Downloads)    
Type of Study: Research | Subject: General

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.